ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Patients Sue Milken, Cancer Centers, Over Prostate Cancer Remedy PC-Spes

February 20, 2004

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994